06/07/2024 10:35 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 4:27 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form DEF 14A | |
05/30/2024 3:45 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form D Notice of Exempt Offering of Securities | |
05/23/2024 4:19 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form PRE 14A | |
05/20/2024 4:28 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
05/16/2024 7:02 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 11:21 AM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) Schulke Ryan (Filed by)
| Form SC 13D/A | |
|
05/16/2024 11:22 AM | Conlin Matthew (Filed by) Cogent Biosciences (Subject) Fluent, Inc. (Subject)
| Form SC 13D/A | |
05/15/2024 8:55 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 8:30 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2024 3:50 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024 3:18 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 4:22 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/29/2024 4:21 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form ARS | |
04/02/2024 3:21 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/18/2024 4:18 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/14/2024 5:01 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 4:57 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:16 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:17 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 5:26 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Perfit Ryan MacNab (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:43 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 8:40 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:41 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2024 4:43 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:23 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:24 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
03/06/2024 5:25 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/06/2024 5:25 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Perfit Ryan MacNab (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 11:05 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 4:51 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) JB CAPITAL PARTNERS LP (Filed by)
| Form SC 13G/A | |
02/12/2024 3:54 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form DEF 14A | |
02/08/2024 9:30 AM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) WELLINGTON TRUST Co N A (Filed by)
| Form SC 13G/A | |
02/01/2024 3:50 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form PRE 14A | |
01/19/2024 3:36 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/29/2023 2:32 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 3:05 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) GLOBAL VALUE INVESTMENT CORP. (Filed by)
| Form SC 13D/A | |
12/18/2023 4:57 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2023 4:58 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 9:23 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 9:28 AM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Top 5 Tech Stocks to Buy for 2024 (Ad) The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world's most powerful tech companies (including Microsoft, Intel, and Google) investing billions. And one tiny company will be the driving force behind this new tech revolution… Click below for your free report "Top 5 Tech Stocks to Buy in 2024", |
12/13/2023 10:21 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 8:54 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 8:57 AM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/08/2023 1:50 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:44 AM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/07/2023 7:46 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Perfit Ryan MacNab (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 5:13 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:46 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4/A | |
11/30/2023 7:59 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:01 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 5:32 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 5:25 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 8:23 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Schulke Ryan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2023 8:28 PM | Conlin Matthew (Reporting) Cogent Biosciences (Issuer) Fluent, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2023 3:48 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form NT 10-Q | |
11/15/2023 3:50 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2023 3:42 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 4:24 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/25/2023 3:34 PM | Cogent Biosciences (Subject) Fluent, Inc. (Subject) FROST PHILLIP MD ET AL (Filed by)
| Form SC 13D/A | |
09/21/2023 3:44 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Frost Gamma Investments Trust (Reporting) FROST PHILLIP MD ET AL (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/15/2023 4:26 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form NT 10-Q | |
07/18/2023 4:29 PM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/26/2023 10:29 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Patrick Donald Huntley (Reporting)
| Form 4/A | |
06/15/2023 10:21 AM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Graff David Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 8:53 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) SHATTUCK KOHN BARBARA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 8:55 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) Mathis Donald H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 8:58 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) PFENNIGER RICHARD C JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 8:51 PM | Cogent Biosciences (Issuer) Fluent, Inc. (Issuer) NEWELL CARLA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 9:01 AM | Cogent Biosciences (Filer) Fluent, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |